Lifeboat Foundation

We are excited to announce a high-stakes debate on one of humanity’s oldest enigmas: aging. This event is not just a discussion, but a contest with a grand prize of 10,000 USDT for the winner. The debate aims to tackle the various theories and methodologies related to aging and seeks to uncover actionable insights through rigorous scientific discourse.

More info 👉 https://openlongevity.org/debates.

Continue reading “Debates: How to Defeat Aging — $10K Prize! Aubrey de Grey VS Peter Fedichev” »

People with a rare mutation that causes Laron syndrome, a form of dwarfism, live healthier lives and could be the key to anti-aging drugs.

For humanity’s sake, regulation is needed to tame market forces, argue Helen Toner and Tasha McCauley.

#LongevityWe’re born, we grow old, we die. It’s a rhythm long considered inevitable. But is it? Or is aging merely a disease awaiting…

2BP

2-Stage Backpropagation.

As Deep Neural Networks (DNNs) grow in size and complexity, they often exceed the memory capacity of a single accelerator, necessitating the sharding of model parameters across multiple accelerators.

Continue reading “2BP: 2-Stage Backpropagation” »

Space lovers have an opportunity to watch two unique occurrences at the International Space Station this week, but you will have to stay up pretty late — or wake up very early — to see them live.

According to NASA, the cargo spacecraft carrying three tons of food, fuel and supplies to the ISS is for the Expedition 71 crew.

The unpiloted spacecraft – called Progress 88 – is scheduled to launch on a Soyuz rocket from the Baikonur Cosmodrome in Kazakhstan on Thursday at 2:43 p.m. local time.

New symptoms such as failing to identify more than one object at a time and a “space perception deficit” could be the first signs of Alzheimer’s disease, a new study has found.

Posterior cortical atrophy (PCA), is a diagnosis for those who struggle with judging distances, distinguishing between moving and stationary objects and completing tasks like writing and it overwhelmingly predicts Alzheimer’s.

In the latest study from researchers at the University of California, San Francisco, some 94 per cent patients with PCA had Alzheimer’s pathology. Most patients with PCA have normal cognition early on, but by the time of their first diagnostic visit, an average 3.8 years after symptom onset, mild or moderate dementia was apparent with deficits identified in memory, executive function, behavior, and speech and language , according to the researchers’ findings.

The team spent years perfecting an intricate process for manufacturing two-dimensional arrays of atom-sized qubit microchiplets and transferring thousands of them onto a carefully prepared complementary metal-oxide semiconductor (CMOS) chip. This transfer can be performed in a single step.

“We will need a large number of qubits, and great control over them, to really leverage the power of a quantum system and make it useful. We are proposing a brand new architecture and a fabrication technology that can support the scalability requirements of a hardware system for a quantum computer,” says Linsen Li, an electrical engineering and computer science (EECS) graduate student and lead author of a paper on this architecture.

Researchers from the University of Oxford have developed a new small molecule that can suppress the evolution of antibiotic resistance in bacteria and make resistant bacteria more susceptible to antibiotics. The paper, “Development of an inhibitor of the mutagenic SOS response that suppresses the evolution of quinolone antibiotic resistance,” has been published in the journal Chemical Science.